Periostin drives extracellular matrix degradation, stemness, and chemoresistance by activating the MAPK/ERK signaling pathway in triple-negative breast cancer cells.

Authors:
Wu J; Li J; Xu H; Qiu N; Huang X and 1 more

Journal:
Lipids Health Dis

Publication Year: 2023

DOI:
10.1186/s12944-023-01912-1

PMCID:
PMC10504790

PMID:
37716956

Journal Information

Full Title: Lipids Health Dis

Abbreviation: Lipids Health Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nutrition & Dietetics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalThe human subjects of this study were approved by the Medical Ethics Committee of Affiliated Cancer Hospital & Institute of Guangzhou Medical University, and signed informed consent forms were obtained from each subject. Competing interestsThe authors declare no conflicts of interest. Competing interests The authors declare no conflicts of interest."

Evidence found in paper:

"This study was supported by the China Postdoctoral Science Foundation (2022M720914) and the National Natural Science Foundation of China (82072899, 82002778)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025